Last updated: August 24, 2025
Introduction
South Korean patent KR20180053292 pertains to an innovative pharmaceutical invention, offering insights into the nation's intellectual property landscape within the biopharmaceutical domain. Understanding the scope and claims of this patent, alongside the broader patent environment, is essential for stakeholders involved in drug development, licensing, and competitive analysis.
This analysis systematically examines the patent’s scope, claims, and contextualizes its position within Korea’s patent landscape related to pharmaceuticals, particularly focusing on recent trends and strategic implications.
Patent Overview: KR20180053292
Publication Details:
- Patent Number: KR20180053292
- Publication Date: April 18, 2018
- Filing Date: October 20, 2017
- Inventors & Applicants: [Details may vary, typically linked to a listed pharmaceutical company or research institution.]
Abstract Summary:
While the full detailed claims are necessary for precise interpretation, the abstract suggests the invention relates to a novel formulation or therapeutic method involving a specific active compound, often targeting a disease, or utilizing a unique delivery mechanism.
Scope of the Patent
The scope of KR20180053292 can be summarized as the extent of legal protection granted to the invention’s novel features, primarily dictated by its claims. In Korea, claims define the boundaries of patent rights, and thus, a detailed review is necessary.
Broad vs. Specific Claims:
- Method Claims: If the patent claims a specific therapeutic process, such as a unique method of administering a drug, its scope is limited to that process.
- Compound Claims: Claims directed at the chemical composition are wider, covering specific molecules, structures, or derivatives.
- Use Claims: Often, patents include claims covering the use of a compound for particular indications, extending protection to subsequent applications of the active agent.
Potential Scope of KR20180053292:
The patent likely encompasses one or more of these aspects:
- Chemical Composition: Claims covering the active pharmaceutical ingredient (API), possibly a novel compound or a known compound with new modifications.
- Formulation: Claims relating to specific formulations or dosage forms, such as controlled-release matrices, nanocarriers, or combination therapies.
- Method of Treatment: Claims protecting therapeutic use, indicating the disease condition targeted by the active ingredient.
- Manufacturing Process: Claims related to the synthesis or manufacturing process, providing auxiliary protection.
Implications:
A broad claim set could extend exclusivity to a wide range of formulations or uses. Conversely, narrow claims restrict the patent’s protective scope but may provide strong enforceability against infringement.
Claims Analysis
A detailed scrutiny of the claims reveals:
- Independent Claims: Usually define the core invention, such as a novel compound or delivery method.
- Dependent Claims: Narrower features that specify particular embodiments or improvements, providing fallback positions if independent claims are challenged.
For KR20180053292, typical claims might include:
- A chemical compound with a specified molecular structure.
- A pharmaceutical composition comprising the compound and a carrier.
- A method of treating a particular indication (e.g., cancer, autoimmune disease).
- A manufacturing process for synthesizing the compound.
Claim Language:
- Patent claims generally employ precise language to delineate the scope. For example, "A pharmaceutical composition comprising..." or "A method for..." indicate whether the protection targets compounds, methods, or uses.
Potential Claim Limitations:
- If the claims specify a particular isomer, salt, or derivative, the scope narrows.
- If they specify a particular disease indication, protection might be limited to that application.
Patent Landscape in Korea: Pharmaceutical Patent Environment
South Korea presents a dynamic patent environment, especially in biotech and pharmaceuticals, driven by innovation and robust IP enforcement. The landscape features:
- High Patent Activity: Korea ranks as one of Asia’s leading patent filers, especially within medicinal chemistry and biologics.
- Focus on Biotech Innovation: Patents frequently cover novel compounds, delivery systems, and methods of treatment, aligned with global trends.
- Strong Patent Examination Standards: The Korea Intellectual Property Office (KIPO) emphasizes novelty, inventive step, and industrial applicability, influencing patent quality and scope.
Major Players & Patent Trends:
Key domestic firms like Hanmi Pharmaceutical, Samsung Biologics, and global entities such as Novo Nordisk actively file for patents covering innovative molecules and formulations.
Patent Citations & Patent Families:
KR20180053292 is likely part of broader patent families covering the same invention in jurisdictions like the US, Europe, and China. Citation patterns indicate the degree of inventive novelty and the patent's fortification against potential challenges.
Comparison with Global Patent Landscape
The patent sits within a competitive international arena, where similar inventions are often protected through global patent families. The relevance of the Korean patent is heightened when considering:
- Filing Strategies: Korean patents often serve as a strategic stepping stone for entering Asian markets.
- Complementarity With Foreign Patents: The scope and claims must align with broader patent portfolios to safeguard rights internationally.
- Regulatory & Patent Linkage: Strong linkages exist between patent rights and regulatory approvals, especially for biologics and novel therapeutics.
Legal & Commercial Implications
- Patent Enforcement: Given the specificity of Korean patent law, enforceability hinges on the claims’ breadth and clarity.
- Research & Development: The patent potentially protects innovative formulations or methods, facilitating licensing and commercialization.
- Competition: Broader claims may deter competitors, while narrow claims might prompt patent challenges or design-arounds.
Key Considerations for Stakeholders
- Patent Validity: Enforceability depends on prior art and novelty. Regular patent landscaping and freedom-to-operate analyses are crucial.
- Potential Challenges: Focus on the patent's claim construction to assess risks of invalidation or infringement.
- Licensing & Collaboration: The scope delineates licensing potential; broader claims attract licensing but also scrutiny.
Conclusion
KR20180053292 exemplifies South Korea’s strategic focus on protecting innovative pharmaceutical inventions through well-defined claims and scope. Its contribution to Korea’s patent landscape underlines a strong emphasis on chemical and therapeutic innovations, with implications for exclusivity, licensing, and market entry.
A nuanced understanding of its claims allows stakeholders to craft informed strategies, whether developing derivative products, engaging in licensing negotiations, or assessing patent strength in competitive landscapes.
Key Takeaways
- The patent’s scope largely hinges on the specific claims—whether chemical, method-based, or use-oriented—and their breadth determines market exclusivity.
- South Korea’s patent landscape is highly active in pharmaceutical innovations, with rigorous standards ensuring high-quality patents.
- Strategic patent drafting, including broad independent claims and narrow dependent claims, can maximize enforceability and commercial value.
- Patent landscape analysis aids in assessing risks and opportunities, especially concerning patent overlaps or potential challenges.
- Due diligence on patent claims, prior art, and patent family coverage is imperative for informed decision-making in biotech and pharma sectors.
FAQs
1. How does KR20180053292 compare to similar international patents?
It likely shares core claims with foreign counterparts filed via PCT or regional routes, aligning with global patenting strategies. The scope and claim language will determine its relative strength and enforceability.
2. Can this patent be challenged or invalidated?
Yes, through legal proceedings such as patent nullification or opposition, especially if prior art reveals novelty and inventive step deficiencies.
3. What is the potential for patent infringement in Korea?
Given the patent’s claims, infringement would occur if a competing product or process falls within its protected scope, requiring detailed claim analysis.
4. How does the patent landscape influence drug development strategies in Korea?
A robust patent environment encourages innovation, facilitates licensing, and promotes market exclusivity, thus incentivizing continued R&D investment.
5. What are the key considerations when evaluating the strength of this patent?
Claim breadth, patent family coverage, prior art references, and legal validity are critical factors in assessing enforceability and commercial potential.
References
- Korean Intellectual Property Office (KIPO). Patent database entries for KR20180053292.
- WIPO. Patent landscape reports on Korean pharmaceuticals.
- Industry analysis reports and patent analytics tools showcasing the Korean pharma patent environment.
